Iron deficiency anemia is the most common hematological but manageable health problem encountered among the pregnant women globally but more common in developing countries like India.
Methods: It is interventional prospective comparative study conducted in Department of Obstetrics and Gynaecology at Dr. Yashwant Singh Parmar Govt. Medical College & Hospital Nahan, Sirmour (H.P) over a period of 2years from April 2017- April 2019. 100 pregnant patients with hemoglobin in the range 7gm/dl - 9 gm/dl between 16 to 34 weeks gestation were selected randomly. Patients were divided into two groups 50 each. Group 1 is Iron Sucrose (IS) group- patients were treated with intravenous iron sucrose in multiple doses on alternate days on 0,2,4,6 and 8, 200mg per day, total of 1000mg. Group 2 is Ferric Carboxymaltose (FCM) group were treated with intravenous FCM 1000mg single dose. In both group Hemoglobin and Serum ferritin were assessed before and after (3 & 6 weeks) parenteral therapy.
Results: There is significant rise of hemoglobin >2 gm/dl in Group 2 (FCM) as compared to in Group 1 (Iron sucrose). The single dose regime of FCM group was having very good compliance as compared to Iron sucrose group.
Intravenous Ferric carboxymaltose is more effective and safer as compared to Intravenous Iron sucrose in the management of anemia during pregnancy.